WO2022015133A1 - Mousse antiseptique de protection cutanée - Google Patents
Mousse antiseptique de protection cutanée Download PDFInfo
- Publication number
- WO2022015133A1 WO2022015133A1 PCT/MX2020/000025 MX2020000025W WO2022015133A1 WO 2022015133 A1 WO2022015133 A1 WO 2022015133A1 MX 2020000025 W MX2020000025 W MX 2020000025W WO 2022015133 A1 WO2022015133 A1 WO 2022015133A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- skin
- antiseptic
- foam
- water
- Prior art date
Links
- 239000004599 antimicrobial Substances 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 24
- -1 alkalis Substances 0.000 claims abstract description 11
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 10
- 239000006260 foam Substances 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 10
- 239000002253 acid Substances 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 150000007513 acids Chemical class 0.000 claims abstract description 5
- 239000003921 oil Substances 0.000 claims abstract description 5
- 239000003973 paint Substances 0.000 claims abstract description 5
- 231100000252 nontoxic Toxicity 0.000 claims abstract description 3
- 230000003000 nontoxic effect Effects 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 11
- 239000000645 desinfectant Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 230000007794 irritation Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- 230000001681 protective effect Effects 0.000 claims description 6
- 239000000344 soap Substances 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 239000003205 fragrance Substances 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 4
- 239000004166 Lanolin Substances 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 4
- 229940039717 lanolin Drugs 0.000 claims description 4
- 235000019388 lanolin Nutrition 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 239000003925 fat Substances 0.000 claims description 3
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 206010020751 Hypersensitivity Diseases 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 238000005336 cracking Methods 0.000 claims description 2
- 238000012864 cross contamination Methods 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000012456 homogeneous solution Substances 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 230000001012 protector Effects 0.000 claims description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- 230000000475 sunscreen effect Effects 0.000 claims description 2
- 239000000516 sunscreening agent Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 abstract description 2
- 238000005553 drilling Methods 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract description 2
- 244000052769 pathogen Species 0.000 abstract description 2
- 239000004519 grease Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 18
- 230000000844 anti-bacterial effect Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 13
- 235000019441 ethanol Nutrition 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000010410 layer Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001263478 Norovirus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000006266 hydroalcoholic foam Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000004821 Contact adhesive Substances 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241001502129 Mullus Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940060038 chlorine Drugs 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000006254 rheological additive Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Definitions
- the present invention is directed to the field of broad-spectrum dermal disinfectants for local application. Particularly to aqueous solutions in the form of foam that produce a protective film, which prevents microbial contamination from bacteria, fungi and viruses, as well as protection against different types of chemicals.
- Antibacterial gels, antiseptics or hand sanitizers make our lives easier in this hygiene-obsessed age. They are seen everywhere: in public bathrooms, in hospitals, in gyms, at the entrance and exit of places with a lot of human traffic, installed in easy-to-operate dispensers. In addition, they are easy to carry in your pocket in small plastic bottles. Just a few drops and that's it, hands are considered clean and disinfected.
- US Centers for Disease Control and Prevention indicates that hand sanitizers and antibacterial gels are not as effective against some types of.
- Antibacterial gels don't work very well, such as when hands are very oily or dirty. These conditions can occur when camping, playing sports or gardening. Antibacterial products are also not very good at removing harmful chemicals from your hands, such as pesticides and heavy metals.
- Hand gels do not protect against salmonella, e. coli, antibiotic-resistant Staphylococcus aureus (MRSA), and norovirus, which can cause serious complications, including death. These four diseases can be spread from person to person. In the case of the mullet and the e. coli, cause diarrhea that can be fatal in severe cases. The contagion can happen through contact with feces or with food that has not been properly refrigerated.
- MRSA antibiotic-resistant Staphylococcus aureus
- Norovirus is a common disease that is often contracted on cruise ships and is easily transmitted between passengers and crew. It is the main cause of the symptoms of gastroenteritis or "intestinal flu” and antibacterial gels simply cannot kill it. In the case of the coronavirus, they can be effective, but only as a temporary measure, while you have access to soap and water.
- Patent application MX/a/2017/005243; BIODEGRADABLE AND ANTIBACTERIAL ORGANIC GEL FOR HANDS AND SKIN describes an organic gel for hands and skin that is biodegradable and antibacterial, characterized by being made based on carbomer, triethanolamine, glycerin and chitosan, which does not affect the environment or cause skin irritation or in the hands.
- a composition of crystalline antibacterial gel for hands with citrus fragrance with moisturizing characteristics is provided that has main application in places where water is scarce; of daily use several times a day, and is suitable for children. This is achieved by adding natural humectants and using an antibacterial disinfectant agent, pure cane ethyl alcohol.
- the composition consists of different compounds comprising; rheological modifier, sequestrant, fragrance, emulsifier, neutralizer, humectant, solvent and disinfectant.
- the application PA/A/2008/014962, ANTIBACTERIAL AND ANTICORROSIVE COMPOSITION FOR THE PROTECTION OF THE SKIN provides an aqueous emulation comprising from 50% to 85.0% of water, from 0.5% to 5.0% of other ingredients such as the active ingredient, the active ingredient includes but is not limited to oil-soluble vitamins, water-soluble vitamins, active fatty acids, fatty acids, fatty alcohol esters of fatty acids, hydrocarbons, liquid and solid wax and silicone liquids of various types, the composition it can also include preservatives and fragrance oils, the compositions can also include essential oils, with a layer that applied to the skin will remain insoluble in water, this layer protects the skin when it dries, even against friction.
- the composition can be applied to skin of different pharmaceutical forms, these application forms include but are not limited to gel, creams, lotions, sprays, ointments and aerosols.
- An alternative solution is antiseptic foams, which are based on alcoholic antiseptic solutions. Alcoholic antiseptic solutions are used to reduce the number of viable microorganisms on the hands, reducing the risk of spreading infectious diseases.
- These products contain antiseptic agents or antimicrobial substances, including alcohols, chlorhexidine, chlorine, hexachlorophene, iodine, chloroxylenol (PCMX), quaternary ammonium compounds, and triclosan.
- antiseptic agents or antimicrobial substances including alcohols, chlorhexidine, chlorine, hexachlorophene, iodine, chloroxylenol (PCMX), quaternary ammonium compounds, and triclosan.
- the effectiveness of the composition may be similar to that of the antibacterial gel, but the difference is the physical form, liquid or foam.
- the hydro-alcoholic foam solution eliminates the above problems, even with a smaller amount of product, which means lower overall consumption.
- the hydro-alcoholic foam solution is more effective, since the entire dose of product applied remains in the hands without spilling, its distribution is homogeneous, and less quantity is needed to achieve the same effectiveness as in liquid or in gel.
- the object of the present invention is to provide a composition of an antiseptic solution in foam form, where the antiseptic foam that is obtained protects the skin from oils, greases, solvents, paints, alkalis, acids, drilling fluids and pathogens.
- Said antiseptic foam is not toxic, flammable or destructive to the ozone layer.
- it protects the foot! from contact burns with 37% hydrochloric acid and 50% sodium hydroxide; forms a biomechanical layer that adheres to the skin and prevents the absorption of chemical substances through it.
- the antiseptic foam has a pH between 6 and 7, it is completely soluble in water; whose density at 25°C is 1g/ml; and is stable under normal conditions of storage and use for up to 24 months
- the antiseptic foam is a disinfectant, and has a protective action on the skin against: microorganisms, oils, fats, solvents, paints, alkalis, acids, etc. Its disinfectant and protective action have an effective effect for 4 hours. It forms a biomechanical layer that adheres to the skin, preventing the absorption of chemical substances through it. It includes quaternary ammonium salts that have a disinfecting effect against bacteria, fungi and some types of viruses.
- the foam object of the present invention prevents cross contamination for 4 hours; contains quaternary ammonium salts that have disinfectant activity on bacteria (mainly Gram positive), fungi and viruses, thus helping to prevent infections caused by these microorganisms, prevents allergic reactions caused by the latex of the gloves, avoids burns, cracking or irritation caused by contact with irritating substances.
- the antiseptic foam is non-toxic and non-absorbable so it does not impede breathing in the pores or decrease sensitivity. It is free of dyes, fragrances, alcohol and silicone.
- the antiseptic foam is administered and applied after washing the area where the product will be applied with soap and water, rinsing and drying completely. Antiseptic foam is applied, distributing evenly over the entire area; when applying to the hands, make sure that the foam comes into contact with the cuticle and the skin under the nails; it is allowed to air dry. This procedure can be repeated again at 4 hours.
- composition of the antiseptic solution to obtain the antiseptic foam object of the present invention comprises alkyl dimethyl ammonium hydrochloride between 0.1 and 10% p/p, hydroxyethyl cellulose from 10 to 25% p/p, propylene glycol from 5 to 45%, PVP K-30 from 10 to 25% p/p, ethoxylated lanolin 10 to 15%, citric acid 0.1-5%, may also include other excipients or pharmaceutically acceptable additives, such as emollients, moisturizers, sunscreens, UV protectors, among others in pharmaceutically effective amounts and as solvent water.
- composition of the antiseptic solution to obtain the antiseptic foam of the invention is prepared according to the following procedure;
- the composition of the antiseptic solution to obtain the antiseptic foam was tested through the following clinical trials: Hand smears; irritation test; Microbial Challenges and a Verification Study for Performance carried out at the Research Center for Industrial Development of the Autonomous University of Guadalajara. a) Hand smears:
- the antiseptic foam object of the present invention has antimicrobial effectiveness for up to a maximum of 4 hours.
- the irritability test showed that the antiseptic foam of the invention is not irritating to human skin.
- a statistically representative sample of individuals had antiseptic foam applied to their hands, arms, and legs. They were asked to rate the sensation of irritation on a scale from 0 to 5. The sensation of irritation was subject to visual tactile verification in the area of application of the foam.
- the final average irritation index was 0.0, that is, the product is not irritating.
- the results of the microbial challenges are shown below: d) The Verification Study for the performance of the antiseptic foam of the invention, demonstrated the effectiveness of protection for 4 (four) hours with a single application against products with different characteristics, such as acidic and basic pH's, easy removal of paints, fats and contact adhesives, as well as demonstrate that it avoids dryness when using organic solvents such as the so-called "thinner”.
- the volunteers of the 8 groups washed their hands with soap and water, dried their hands, after which an amount of antiseptic foam object of the invention was applied to one hand and allowed to dry.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXMX/A/2020/005510 | 2020-07-13 | ||
MX2020005510A MX2020005510A (es) | 2020-07-13 | 2020-07-13 | Espuma antiseptica protectora de piel. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022015133A1 true WO2022015133A1 (fr) | 2022-01-20 |
Family
ID=79554950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/MX2020/000025 WO2022015133A1 (fr) | 2020-07-13 | 2020-08-06 | Mousse antiseptique de protection cutanée |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX2020005510A (fr) |
WO (1) | WO2022015133A1 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2247555C1 (ru) * | 2003-12-19 | 2005-03-10 | Бородкина Татьяна Владимировна | Гель антибактериальный |
CN107536727A (zh) * | 2017-08-28 | 2018-01-05 | 上海美浮特生物科技有限公司 | 一种免洗手皮肤抗菌泡沫及其制备方法 |
CN107714501A (zh) * | 2017-10-24 | 2018-02-23 | 山东新华医疗器械股份有限公司 | 一种无醇泡沫手消毒液 |
CN110960432A (zh) * | 2019-12-21 | 2020-04-07 | 中山市川林生物科技有限公司 | 一种泡沫洗手液及其制备方法 |
-
2020
- 2020-07-13 MX MX2020005510A patent/MX2020005510A/es unknown
- 2020-08-06 WO PCT/MX2020/000025 patent/WO2022015133A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2247555C1 (ru) * | 2003-12-19 | 2005-03-10 | Бородкина Татьяна Владимировна | Гель антибактериальный |
CN107536727A (zh) * | 2017-08-28 | 2018-01-05 | 上海美浮特生物科技有限公司 | 一种免洗手皮肤抗菌泡沫及其制备方法 |
CN107714501A (zh) * | 2017-10-24 | 2018-02-23 | 山东新华医疗器械股份有限公司 | 一种无醇泡沫手消毒液 |
CN110960432A (zh) * | 2019-12-21 | 2020-04-07 | 中山市川林生物科技有限公司 | 一种泡沫洗手液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
MX2020005510A (es) | 2022-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI498423B (zh) | 抗微生物性組成物 | |
ES2389440T3 (es) | Una formulación emoliente de alcohol para desinfectar la piel | |
RU2465891C2 (ru) | Антибактериальные композиции, продукты и способы их применения | |
US5403587A (en) | Disinfectant and sanitizing compositions based on essential oils | |
Glaser | The ubiquitous triclosan | |
TW201201856A (en) | Antimicrobial compositions | |
KR20150097560A (ko) | 식물성 항균 조성물 | |
ES2445034T3 (es) | Composiciones para la desinfección higiénica de manos y el lavado desinfectante de manos | |
US8741271B2 (en) | Antimicrobial compositions containing essential oils | |
JP2013506650A (ja) | サニタイジング組成物 | |
JP2005530857A (ja) | 抗菌組成物、抗菌製品、及びそれらを使用する方法 | |
US8147877B2 (en) | Essential oils based disinfecting compositions having tuberculocidal and fungicidal efficacies | |
BR112012028719B1 (pt) | composição de tratamento de superfície dura, método para fornecer um efeito antimicrobiano e uso de uma combinação | |
US20090069436A1 (en) | Antimicrobial skin composition comprising a biguanide or a quaternium compound | |
CN111727076A (zh) | 消毒组合物以及制备和使用其的方法 | |
US20140030203A1 (en) | Antimicrobial compositions containing essential oils | |
EP0457805A1 (fr) | Desinfectant biodegradable | |
JP2015500817A (ja) | 抗菌剤組成物 | |
BR112014013615B1 (pt) | Composição microbicida sinérgica | |
WO2022015133A1 (fr) | Mousse antiseptique de protection cutanée | |
BR112014013605B1 (pt) | Composições microbicidas sinérgicas compreendendo álcool antimicrobiano e fenol substituído | |
BR112014013603B1 (pt) | Composição microbicida sinérgica que compreende um composto fenólico e um álcool terpeno | |
BR112014013607B1 (pt) | composição sinergética microbicida | |
WO2022182217A1 (fr) | Mousse germicide pour la peau | |
ES2277210T3 (es) | Composicion contra la infestacion de piojos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20945338 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20945338 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 02.08.2023) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20945338 Country of ref document: EP Kind code of ref document: A1 |